Literature DB >> 1454086

Sympathetic overactivity in patients with chronic renal failure.

R L Converse1, T N Jacobsen, R D Toto, C M Jost, F Cosentino, F Fouad-Tarazi, R G Victor.   

Abstract

BACKGROUND: Hypertension is a frequent complication of chronic renal failure, but its causes are not fully understood. There is indirect evidence that increased activity of the sympathetic nervous system might contribute to hypertension in patients with end-stage renal disease, but sympathetic-nerve discharge has not been measured directly in patients or animals with chronic renal failure.
METHODS: We recorded the rate of postganglionic sympathetic-nerve discharge to the blood vessels in skeletal muscle by means of microelectrodes inserted into the peroneal nerve in 18 patients with native kidneys who were undergoing long-term treatment with hemodialysis (of whom 14 had hypertension), 5 patients receiving hemodialysis who had undergone bilateral nephrectomy (of whom 1 had hypertension), and 11 normal subjects. RESULTS. The mean (+/- SE) rate of sympathetic-nerve discharge was 2.5 times higher in the patients receiving hemodialysis who had not undergone nephrectomy than in the normal subjects (58 +/- 3 vs. 23 +/- 3 bursts per minute, P < 0.01). In contrast, the rate of sympathetic-nerve discharge was similar in the patients receiving hemodialysis who had undergone bilateral nephrectomy (21 +/- 6 bursts per minute) and the normal subjects. The rate of sympathetic-nerve discharge in the patients receiving hemodialysis who had not undergone nephrectomy was also significantly higher (P < 0.01) than that in the patients with bilateral nephrectomy, and it was accompanied in the former group by higher values for vascular resistance in the calf (45 +/- 4 vs. 22 +/- 4 units, P < 0.05) and mean arterial pressure (106 +/- 4 vs. 76 +/- 14 mm Hg, P < 0.05). The rate of sympathetic-nerve discharge was not correlated with either plasma norepinephrine concentrations or plasma renin activity.
CONCLUSIONS: Chronic renal failure may be accompanied by reversible sympathetic activation, which appears to be mediated by an afferent signal arising in the failing kidneys.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454086     DOI: 10.1056/NEJM199212313272704

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  253 in total

Review 1.  Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma.

Authors:  G Eisenhofer; T T Huynh; M Hiroi; K Pacak
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.

Authors:  D A Sica; T W Gehr; A Fernandez
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 3.  Compelling drug indications in diabetic and nondiabetic nephropathy.

Authors:  Eberhard Ritz; Ralf Dikow; Martin Zeier
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 4.  Improved blood pressure control with nocturnal hemodialysis: review of clinical observations and physiologic mechanisms.

Authors:  Brendan B McCormick; Christopher T Chan
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

5.  Renal intervention to treat hypertension.

Authors:  Rajan A G Patel; Christopher J White
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 6.  AKI and the Neuroimmune Axis.

Authors:  Shinji Tanaka; Mark D Okusa
Journal:  Semin Nephrol       Date:  2019-01       Impact factor: 5.299

7.  Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation.

Authors:  Jason D Foss; Gregory D Fink; John W Osborn
Journal:  Hypertension       Date:  2013-02-04       Impact factor: 10.190

8.  Effect of icodextrin on heart rate variability in diabetic patients on peritoneal dialysis.

Authors:  Oscar Orihuela; María de Jesús Ventura; Marcela Ávila-Díaz; Alejandra Cisneros; Marlén Vicenté-Martínez; María-del-Carmen Furlong; Zuzel García-González; Diana Villanueva; Guadalupe Alcántara; Bengt Lindholm; Elvia García-López; Cleva Villanueva; Ramón Paniagua
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

Review 9.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

10.  Renal function is associated with risk of atrial fibrillation after cardiac surgery.

Authors:  Johann Auer; Gudrun Lamm; Thomas Weber; Robert Berent; Choi-Keung Ng; Michael Porodko; Bernd Eber
Journal:  Can J Cardiol       Date:  2007-09       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.